$TOVX Biotech Momentum 🚀 Up 60% Premarket! 🔹 Theriva Biologics is ripping as traders rotate back into high-risk oncology names 📈 🔹 Company is developing onc

$TOVX Biotech Momentum 🚀 Up 60% Premarket! 🔹 Theriva Biologics is ripping as traders rotate back into high-risk oncology names 📈 🔹 Company is developing oncolytic virus therapies targeting difficult-to-treat cancers 🧬 🔹 Lead candidate VCN-01 is focused on metastatic pancreatic cancer, one of t…